158 related articles for article (PubMed ID: 38657195)
21. A nationwide survey of opsoclonus-myoclonus syndrome in Japanese children.
Hasegawa S; Matsushige T; Kajimoto M; Inoue H; Momonaka H; Oka M; Ohga S; Ichiyama T;
Brain Dev; 2015 Aug; 37(7):656-60. PubMed ID: 25454391
[TBL] [Abstract][Full Text] [Related]
22. Opsoclonus-myoclonus in children associated or not with neuroblastoma.
Krug P; Schleiermacher G; Michon J; Valteau-Couanet D; Brisse H; Peuchmaur M; Sarnacki S; Martelli H; Desguerre I; Tardieu M
Eur J Paediatr Neurol; 2010 Sep; 14(5):400-9. PubMed ID: 20110181
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus.
Bataller L; Graus F; Saiz A; Vilchez JJ;
Brain; 2001 Feb; 124(Pt 2):437-43. PubMed ID: 11157570
[TBL] [Abstract][Full Text] [Related]
24. Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-up.
Catsman-Berrevoets CE; Aarsen FK; van Hemsbergen ML; van Noesel MM; Hakvoort-Cammel FG; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2009 Dec; 53(6):1048-53. PubMed ID: 19672966
[TBL] [Abstract][Full Text] [Related]
25. [Opsoclonus-myoclonus syndrome in children with neuroblastoma: description of 3 cases].
Garus K; Balwierz W; Skowronek B; Szweda E; Kroczka S; Moryl-Bujakowska A
Przegl Lek; 2010; 67(6):427-9. PubMed ID: 21344775
[TBL] [Abstract][Full Text] [Related]
26. The association between neuroblastoma and opsoclonus-myoclonus syndrome: a historical review.
Rothenberg AB; Berdon WE; D'Angio GJ; Yamashiro DJ; Cowles RA
Pediatr Radiol; 2009 Jul; 39(7):723-6. PubMed ID: 19430769
[TBL] [Abstract][Full Text] [Related]
27. Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group.
Russo C; Cohn SL; Petruzzi MJ; de Alarcon PA
Med Pediatr Oncol; 1997 Apr; 28(4):284-8. PubMed ID: 9078325
[TBL] [Abstract][Full Text] [Related]
28. Childhood opsoclonus-myoclonus syndrome: diagnosis and treatment.
Blaes F; Dharmalingam B
Expert Rev Neurother; 2016 Jun; 16(6):641-8. PubMed ID: 27095464
[TBL] [Abstract][Full Text] [Related]
29. Successful use of tacrolimus for treatment-refractory neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: A case series.
Delap S; Shah N; Kuns O; Franklin B; Skeens MA
Pediatr Blood Cancer; 2024 Apr; 71(4):e30903. PubMed ID: 38321586
[TBL] [Abstract][Full Text] [Related]
30. Mood and behavioral dysfunction with opsoclonus-myoclonus ataxia.
Turkel SB; Brumm VL; Mitchell WG; Tavare CJ
J Neuropsychiatry Clin Neurosci; 2006; 18(2):239-41. PubMed ID: 16720803
[TBL] [Abstract][Full Text] [Related]
31. Ovarian Teratoma-Related Paraneoplastic Neurological Syndromes.
Lin J; Wang M; Wang J; Li J
Front Oncol; 2022; 12():892539. PubMed ID: 35651803
[TBL] [Abstract][Full Text] [Related]
32. Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus-syndrome.
Korfei M; Fühlhuber V; Schmidt-Wöll T; Kaps M; Preissner KT; Blaes F
J Neuroimmunol; 2005 Dec; 170(1-2):150-7. PubMed ID: 16203043
[TBL] [Abstract][Full Text] [Related]
33. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.
Cooper R; Khakoo Y; Matthay KK; Lukens JN; Seeger RC; Stram DO; Gerbing RB; Nakagawa A; Shimada H
Med Pediatr Oncol; 2001 Jun; 36(6):623-9. PubMed ID: 11344493
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcome of ten children with opsoclonus-myoclonus syndrome.
Klein A; Schmitt B; Boltshauser E
Eur J Pediatr; 2007 Apr; 166(4):359-63. PubMed ID: 17089089
[TBL] [Abstract][Full Text] [Related]
35. Ofatumumab for refractory opsoclonus-myoclonus syndrome following treatment of neuroblastoma.
Ketterl TG; Messinger YH; Niess DR; Gilles E; Engel WK; Perkins JL
Pediatr Blood Cancer; 2013 Dec; 60(12):E163-5. PubMed ID: 23813921
[TBL] [Abstract][Full Text] [Related]
36. Clinical Profile, Prognostic Indicators, and Therapeutic Outcomes of Pediatric Opsoclonus-Myoclonus-Ataxia Syndrome: A Single-Center Experience from South India.
Muthusamy K; Thomas M; Yoganathan S; Sudhakar SV
Ann Indian Acad Neurol; 2019; 22(3):295-301. PubMed ID: 31359941
[TBL] [Abstract][Full Text] [Related]
37. [A case report on cervical neuroblastoma with ataxia].
Kanemura N; Nakano T; Hirano A; Amatsu H; Koshimo N; Uemura G; Aiba T
Nihon Jibiinkoka Gakkai Kaiho; 2011 May; 114(5):505-10. PubMed ID: 21702171
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective.
Rossor T; Yeh EA; Khakoo Y; Angelini P; Hemingway C; Irani SR; Schleiermacher G; Santosh P; Lotze T; Dale RC; Deiva K; Hero B; Klein A; de Alarcon P; Gorman MP; Mitchell WG; Lim M;
Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35260471
[TBL] [Abstract][Full Text] [Related]
39. Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma.
Burke MJ; Cohn SL
Pediatr Blood Cancer; 2008 Mar; 50(3):679-80. PubMed ID: 16900484
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes in China.
Cai MT; Qiao S; Lai QL; Zheng Y; Yang F; Fang GL; Shen CH; Zhang YX; Ding MP
Front Immunol; 2022; 13():790400. PubMed ID: 35173717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
